NCT02170805View on ClinicalTrials.gov

Bioavailability of BIBR 1048 MS Single Doses With or Without Pantoprazole in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 30, 2001

Primary Completion Date

June 30, 2001

Conditions
Healthy
Interventions
DRUG

BIBR 1048 MS capsule formulation A

BIBR 1048 MS, formulation A 50 mg

DRUG

BIBR 1048 MS capsule formulation B

BIBR 1048 MS, formulation B 50 mg

DRUG

BIBR 1048 MS powder plus solution

BIBR 1048 MS, powder plus solution 50 mg

DRUG

Pantoprazole

Pantoprazole 40 mg

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02170805 - Bioavailability of BIBR 1048 MS Single Doses With or Without Pantoprazole in Healthy Subjects | Biotech Hunter | Biotech Hunter